上場企業データ
専門・科学・技術サービス業（韓国上場企業）
138社、従業員数の多い順。
企業一覧
| 企業 | 従業員数 | 女性比率 | 男女の給与差 |
|---|---|---|---|
| Samsung E&A 028050 | 5,249 | 10.9% | 23.4% |
| Korea Electronic Power Industrial Development 130660 | 3,614 | 4.2% | 30.1% |
| Dohwa Engineering 002150 | 2,912 | 11.9% | 33.6% |
| KEPCO Engineering & Construction Company 052690 | 2,466 | 21.2% | 28.6% |
| POSCO DX Company 022100 | 2,103 | 19.1% | 18.7% |
| Yooshin Engineering 054930 | 1,988 | 10.1% | 32.3% |
| Korea Engineering Consultants 023350 | 1,907 | 9.5% | 35.5% |
| Cheil Worldwide 030000 | 1,511 | 54.3% | 20.3% |
| Heerim Architects & Planners 037440 | 1,405 | 21.3% | 18.4% |
| Hanyang Eng 045100 | 1,256 | 11.5% | 18.5% |
| Hanmi Global 053690 | 1,120 | 12.6% | 27.4% |
| Innocean Worldwide 214320 | 1,001 | 51.1% | 28.0% |
| GC Cell 144510 | 806 | 35.4% | 6.0% |
| Doosan Tesna 131970 | 786 | 36.9% | 22.8% |
| HS Ad 035000 | 763 | 51.9% | 28.6% |
| SUNGDO Engineering & Construction 037350 | 618 | 7.4% | 26.3% |
| HD Hyundai Marine Solution 443060 | 583 | 23.2% | 39.0% |
| Orbitech 046120 | 556 | 8.6% | 20.3% |
| Revu 443250 | 534 | 56.0% | 37.3% |
| HCT 072990 | 522 | 15.9% | 24.2% |
| C&R Research 359090 | 522 | 82.0% | 26.9% |
| Macrogen 038290 | 488 | 53.9% | 22.0% |
| kt nasmedia 089600 | 400 | 58.8% | 15.5% |
| DreamCIS 223250 | 395 | 79.7% | 12.3% |
| Emnet 123570 | 371 | 65.5% | 27.5% |
| Nepes Ark 330860 | 346 | 29.5% | 29.7% |
| SM Culture & Contents 048550 | 345 | 61.4% | 17.2% |
| WOOJIN Ntec 457550 | 332 | 6.9% | 34.1% |
| DT&CRO 383930 | 314 | 60.8% | 6.5% |
| Dt&C 187220 | 306 | 21.6% | 45.9% |
| Oricom 010470 | 305 | 63.3% | 42.1% |
| PlayD 237820 | 288 | 68.4% | 10.9% |
| Chai Communication 351870 | 275 | 62.5% | 29.2% |
| SK Biopharmaceuticals 326030 | 272 | 50.0% | 19.8% |
| SemiFive 490470 | 270 | 25.9% | 31.6% |
| Itek 119830 | 260 | 37.3% | 18.9% |
| Incross 216050 | 258 | 51.9% | 15.8% |
| Macromill Embrain 169330 | 256 | 70.3% | 29.9% |
| Biotoxtech 086040 | 241 | 54.4% | -1.7% |
| Quality Reliability Technology 405100 | 218 | 26.1% | 25.7% |
| 3billion 394800 | 196 | 45.9% | 8.0% |
| Aurora World 039830 | 187 | 50.8% | 12.8% |
| HLB Pharmaceutical 047920 | 185 | 49.7% | 21.4% |
| LigaChem Biosciences 141080 | 180 | 53.3% | 43.9% |
| Jeio 418550 | 170 | 15.3% | 30.6% |
| Sigong Tech 020710 | 169 | 43.8% | 24.9% |
| GC 005250 | 163 | 39.3% | 22.1% |
| Alteogen 196170 | 161 | 56.5% | 65.1% |
| Wise birds 273060 | 160 | 68.8% | 39.3% |
| Dreaminsight 362990 | 158 | 65.2% | 16.0% |
| Hansung Cleantech 066980 | 152 | 13.8% | 38.1% |
| HLB bioStep 278650 | 150 | 38.0% | 29.8% |
| Voronoi 310210 | 149 | 51.7% | 42.3% |
| Curocell 372320 | 146 | 55.5% | 5.6% |
| LabGenomics 084650 | 142 | 36.6% | 17.0% |
| BioInfra 199730 | 141 | 68.8% | 43.5% |
| JS Link 127120 | 139 | 48.2% | 25.2% |
| GC Genome 340450 | 131 | 63.4% | 26.6% |
| Kolmar BioTech 215380 | 127 | 41.7% | 7.9% |
| Carelabs 263700 | 125 | 49.6% | 46.1% |
| Mobidays 363260 | 124 | 59.7% | 30.7% |
| P&K Skin Research Center 347740 | 121 | 81.0% | 26.8% |
| Fescaro 0015S0 | 111 | 21.6% | 7.6% |
| Penetrium Bioscience 187660 | 110 | 73.6% | 33.6% |
| Gridwiz 453450 | 107 | 31.8% | 18.2% |
| CJ Bioscience 311690 | 102 | 51.0% | 19.3% |
| HEM Pharma 376270 | 101 | 60.4% | 54.7% |
| ZGOO Holdings 221800 | 98 | 41.8% | 29.2% |
| CG Invites 083790 | 92 | 50.0% | 33.3% |
| Vaxcell-Bio Therapeutics 323990 | 91 | 51.6% | 38.5% |
| Organoid Sciences 476040 | 89 | 55.1% | -9.6% |
| Psomagen 950200 | 88 | 52.3% | 23.8% |
| NBT 236810 | 87 | 32.2% | 45.5% |
| Naturalendo Tech 168330 | 83 | 51.8% | 36.3% |
| GI Innovation 358570 | 82 | 48.8% | 16.4% |
| OliX Pharmaceuticals 226950 | 76 | 52.6% | 21.9% |
| Genomictree 228760 | 76 | 56.6% | 41.5% |
| Soulbrain Holdings 036830 | 75 | 32.0% | 26.6% |
| Inventage Lab 389470 | 73 | 26.0% | 20.0% |
| Genematrix 109820 | 69 | 52.2% | 13.6% |
| TiumBio 321550 | 67 | 46.3% | 12.7% |
| Prestige BioPharma 950210 | 67 | 73.1% | 13.3% |
| Genexine 095700 | 66 | 69.7% | 12.2% |
| ToolGen 199800 | 64 | 51.6% | 44.9% |
| IMBdx 461030 | 64 | 56.3% | 38.7% |
| Eone Diagnomics Genome Center 245620 | 63 | 57.1% | 40.2% |
| SLS Bio 246250 | 63 | 60.3% | 6.5% |
| Dx & Vx 180400 | 62 | 45.2% | 38.7% |
| Geninus 389030 | 59 | 47.5% | 32.6% |
| Y-Biologics 338840 | 58 | 58.6% | 34.4% |
| KoBioLabs 348150 | 57 | 54.4% | 37.7% |
| SillaJen 215600 | 56 | 50.0% | -5.0% |
| NGeneBio 354200 | 55 | 56.4% | 40.1% |
| MOA Life Plus 142760 | 54 | 40.7% | 28.7% |
| MedPacto 235980 | 54 | 48.1% | 22.3% |
| Ecoeye 448280 | 54 | 63.0% | 39.3% |
| Aptn 270520 | 53 | 28.3% | 6.8% |
| Proteina 468530 | 53 | 47.2% | 25.0% |
| Aimed Bio 0009K0 | 52 | 55.8% | 26.0% |
| NICE Holdings 034310 | 50 | 14.0% | 57.4% |
| EyeGene 185490 | 49 | 42.9% | 34.1% |
| Aribiolab 261780 | 49 | 71.4% | 24.7% |
| Cellid 299660 | 49 | 51.0% | 19.0% |
| Daesung Holdings 016710 | 47 | 36.2% | 55.4% |
| Simmtech Holdings 036710 | 47 | 25.5% | 27.8% |
| Aptabio Therapeutics 293780 | 45 | 62.2% | 14.1% |
| Helixmith 084990 | 44 | 40.9% | 39.6% |
| Choolip & Sciences 291650 | 44 | 45.5% | 27.7% |
| Quratis 348080 | 44 | 40.9% | 25.8% |
| IntoCell 287840 | 43 | 53.5% | -2.8% |
| ViGenCell 308080 | 43 | 62.8% | -42.4% |
| IMBiologics 493280 | 41 | 58.5% | -7.4% |
| Jeil Pharma Holdings 002620 | 40 | 37.5% | 53.5% |
| BK Holdings 050090 | 40 | 47.5% | 16.0% |
| Oncocross 382150 | 40 | 30.0% | 19.4% |
| NeoImmuneTech 950220 | 40 | 50.0% | 21.1% |
| Cytogen 217330 | 39 | 46.2% | 31.3% |
| Rznomics 476830 | 39 | 56.4% | 24.0% |
| Onconic Therapeutics 476060 | 38 | 63.2% | 1.3% |
| Abion 203400 | 34 | 50.0% | 6.6% |
| Pharos iBio 388870 | 33 | 45.5% | 9.1% |
| Qurient 115180 | 32 | 62.5% | 24.7% |
| Inveni 015360 | 31 | 12.9% | 0.8% |
| curacle 365270 | 31 | 45.2% | 20.0% |
| ADforus 397810 | 30 | 46.7% | 39.7% |
| Sungchang Enterprise Holdings 000180 | 29 | 24.1% | 61.5% |
| AprilBio 397030 | 27 | 55.6% | 79.4% |
| Eusu Holdings 000700 | 23 | 34.8% | -78.4% |
| Kanaph Therapeutics 0082N0 | 23 | 78.3% | 4.7% |
| D&D Pharmatech 347850 | 22 | 59.1% | 52.3% |
| ImmuneOncia Therapeutics 424870 | 22 | 68.2% | 10.0% |
| Mezzion Pharma 140410 | 18 | 22.2% | 34.8% |
| Inventera 0007J0 | 16 | 56.3% | 25.4% |
| Parataxis Korea 288330 | 16 | 56.3% | 16.5% |
| Kainos Medicine 284620 | 15 | 60.0% | -40.7% |
| IDIS Holdings 054800 | 14 | 0.0% | – |
| Asia Holdings 002030 | 10 | 20.0% | 46.3% |
| Solborn 035610 | 5 | 20.0% | 20.0% |
出典：韓国金融監督院 OpenDART、各社の事業報告書「従業員の現況」（2025年度）。KOSPI・KOSDAQ上場企業は毎年、男女別の従業員数、平均勤続年数、1人当たり平均給与を開示しています。The Hardest Marketが集計。